Literature DB >> 22829730

Qualitative and Quantitative analysis of 3D predicted arachidonate 15-lipoxygenase-B (15-LOX-2) from Homo sapiens.

Neha Arora, Vinay Kumar Singh, Kavita Shah, Shashi Pandey-Rai.   

Abstract

15-Lipoxygenase-2 protein has been reported to play an important role in normal development of prostate, lung, skin, and cornea tissues. It behaves as a suppressor of prostate cancer development by restricting cell cycle progression and implicating a possible protective role against tumor formation. On the basis of the above report, we selected 15-LOX-2 protein to study the structural classification and functional relationship with associated protein network at computational level. Sequence alignment and protein functional study shows that it contains a highly conserved LOX motif. PLAT domain with PF01477 and LH2 domain with PF00305 were successfully observed. Arachidonate 5-lipoxygenase (PDB ID: 3O8Y) was selected as a template with 42% identity. 3D structure was successfully predicted and verified. Qualitative analysis suggests that the predicted model was reliable and stable with best quality. Quantitative study shows that the model contained expected volume and area with best resolution. Predicted and best evaluated model has been successfully deposited to PMDB database with PMDB ID PM0078035. Active site identification revealed GLU(369), ALA(370), LEU(371), THR(372), HIS(373), LEU(374), HIS(376), SER(377), HIS(378), THR(385), LEU(389), HIS(394), PHE(399), LYS(400), LEU(401), ILE(403) and PRO(404) residues may play a major role during protein-protein, protein-drug and protein-cofactor interactions. STRING database result indicated that IL (4), GPX (2 and 4), PPARG, PTGS (1 and 2), CYP (2J2, 2C8, 4A11 and 2B6), PLA (2G2A, 2G4A, 2G1B and 2G6) and A LOX (5, 15, 12 and 12B) members from their respective gene families have network based functional association with 15-LOX-2.

Entities:  

Keywords:  3D structure; LOX motif; Qualitative; Quantitative; Ramachandran plot

Year:  2012        PMID: 22829730      PMCID: PMC3398784          DOI: 10.6026/97320630008555

Source DB:  PubMed          Journal:  Bioinformation        ISSN: 0973-2063


Background

Lipoxygenases (LOX) are non-heme, iron-containing lipidperoxidizing enzymes that use molecular oxygen for the dioxygenation of arachidonic acid. They catalyze the formation of hydroperoxides as the first step in the biosynthesis of several inflammatory mediators like leukotrienes and lipoxins [1-3]. The protein consists of a small N-terminal PLAT domain and a major C-terminal catalytic domain containing the active site. The iron atom in LOX is bound by four ligands among which three are histidine residues. Six histidines are conserved in all lipoxygenase sequences, five of them are clustered in a stretch of 40 amino acids. The structure of soybean lipoxygenase-1, determined by X-ray diffraction methods, reveals that 839 amino acids in the protein are organized in two domains viz. beta-sheet N-terminal domain and helical C-terminal domain [1]. LOX are classified according to their positional specificity of the dioxygenation of their most common substrates linoleate (C- 18) in plants, and arachidonic acid (C-20) in mammals [2]. In mammals, LOX have been classified as 5-, 8-, 12-, and 15-LOX. These LOX oxygenate at carbon 5, 8, 12 or 15 of arachidonic acid, forming 5S-, 8S-, 12S-, or 15S-hydroperoxyeicosatetraenoic acid (5-, 8-, 12-, or 15-HPETE) respectively. HPETEs are further reduced by glutathione peroxidase to 5-, 8-, 12-, 15-HETE, which are the hydroxy forms. 15-LOX exists as two isozymes, 15-LOX-1 and 15-LOX-2. The substrate for 15-LOX-1 and 15- LOX-2 are linoleic acid and arachidonic acid, respectively [4, 5]. 15-LOX-2 is recently cloned human lipoxygenase that shows tissue-restricted expression in prostate, lung, skin, and cornea. The protein level and enzymatic activity of 15-LOX-2 have been shown to be down-regulated in prostate cancers compared with normal and benign prostate tissues [6]. Since, 15-LOX-2 structure is not available in any protein structure database so far to understand the functional behavior of this protein, so an in-silico study, mainly comparative homology modeling, of the target sequence 15-LOX-2 can be helpful to investigate sequential-structural-functional relationship. 3D structure of 15- LOX-2 was predicted based on available homologous template structure in Protein structure Data Bank resources. Template selection was performed using Protein Data Bank (PDB) advanced BLAST [7]. Retrieved template structure was used for comparative homology modeling of 15-LOX-2 protein.

Methodology

Retrieval of the target protein sequence:

The protein sequence of 15-lipoxygenase B isoform d (15-LOX- 2) from Homo sapiens was obtained from the protein sequence database of NCBI (Accession No: NP_001132.2) [8]. Since three dimensional structures of 15-LOX-2 for Homo sapiens is not available in Protein structure database (PDB) [9], hence an attempt has been made in the present study to determine the 3D structure of 15-LOX-2 to decipher the functional role of structural motif and secondary elements. ProtParam server [10] was used for computation of various physical and chemical parameters for selected protein.

Template Identification:

The NCBI BLAST was used to identify the template for modeling the three dimensional structure of 15-LOX-2 from Homo sapiens. The result of NCBI BLAST against the PDB database was used for selection of a suitable template for 3D modeling of the target protein.

Sequence alignment:

15-LOX-2 amino acid sequence was used for alignment with template protein using BLAST (bl2seq) [11]. Default parameters were applied and the aligned sequences were inspected and adjusted manually to minimize the number of gaps and insertions.

Homology modeling and Structure refinement:

The three dimensional structure of 15-LOX-2 has been predicted using DS MODELLER. A rough 3D model was constructed based on sequence alignment between 15-LOX-2 of Homo sapiens and the template proteins using Discovery studio 3.1 [12] with selected parameters. Loop refinement and structural simulation were done using LOOPER and CHARMm forcefield, respectively. Finally, predicted 3D model was subjected to a series of tests for testing its internal consistency and reliability. The Quality of the model was checked with verify3D [13], Profile 3D [14] and Errat [15] and the stereochemical properties based on backbone conformation were evaluated by inspection of Psi/Phi/Chi/Omega angle using Ramachandran plot of PDBSum database [15, 16]. Quantitative analysis was done using accessible surface area prediction using Volume Area Dihedral Angle Reporter (VADAR) [17, 18]. Standard bond lengths and bond angles of the model were determined using WHAT IF [15 ,19 &20]. ResProx (Resolution-by-proxy) [21] was also used for quality and quantity measurment using Standard deviation of χ1 pooled, Ramachandran outside of most favored, Deviation of Θ angles, Bump score, Mean H-bond energy, χ1 score, Radius gyration score, Percentage of generously allowed Ω angles, Percentage of packing defects, Percentage of 95% buried residues, Percentage of bad bond length, Percentage of bad bond angles and Ramachandran plot outliers.

Structure Submission:

Successfully modeled, verified and the most reliable structure of 15-LOX-2 was used for deposition in PMDB (Protein Model Database) database [22].

Active Site Prediction:

After complete modeling, simulation and refinement of the structure of 15-LOX-2, it was used for prediction of the possible binding sites using Q-SiteFinder [23]. Ten binding sites were predicted for the target protein. These binding sites were further compared to the active sites of the template.

Prediction of Protein- Protein interaction network:

Protein–Protein functional association network was predicted using STRING database version 9.0 [24].

Results

The selected protein 15-lipoxygenase B (NP_001132.2) has 676 amino acids in length with molecular weight of ~75 kDa. It is 12.4% highly Leucine rich with theoretical pI 5.73. On the basis of sequence similarity analysis, Arachidonate 15-Lipoxygenase- B isoform d showed 62% sequence similarity and 42% identity with template structure (PDB ID 3O8Y). Since the template showed a good level of sequence identity it was used to obtain high quality alignment for structure prediction using homology modeling. A PDB ID 3O8Y crystal structure of stable-5- Lipoxygenase from Human was specifically selected on the basis of BLAST result and was utilized as a template for structure modeling of 15-LOX-2. Structural model was built based on the atomic coordinates of 3O8Y using modeling and simulations program of DS MODELER [25]. The loop refined model, which was selected with minimum CHARMm energy 40839.47232 kcal/mol based on conjugant gradient minimization, was considered for quality and quantity evaluation. 3D predicted model was analyzed using energy minimization, refinement and simulation programs of Discovery studio 3.1. PROCHECK of PDBSum server was employed for the evaluation of stereochemical quality of predicted model. Ramachandran plot analysis showed 90.3 % of amino acid residues within the most favoured and 9.7% residues in additional and generously allowed regions, whereas no residue was found in disallowed region (Figure 1,Figure 2). The structural model of 15-LOX-2 is shown in (Figure 3a). The comparable Ramachandran plot characteristic and G-factor score confirmed the good quality of the predicted model. Based on main-chain and side-chain parameters study, we found that the confirmation of the predicted model was very much favourable, stable and reliable. The 15-LOX-2 model consists of two domains: N-terminal contains Polycystin-1, Lipoxygenase, Alpha-Toxin (PLAT; 4-119) domain, totally arranged with beta sheets and C-terminal has Lipoxygenase homology (LH2; 197- 668) domain, with α-β fold type mainly contains alpha helices. Structural classification of the predicted model revealed that PLAT domain contains only beta sandwich with CATH ID 1.20.245.10 and LH2 domain has mainly alpha fold of up-down bundle type with CATH ID 2.60.60.20. In this predicted 3D model 4 sheets, 7 beta hairpins, 5 beta bulges, 15 strands, 34 helices, 52 helix- helix interacs, 53 beta turns and 7 gamma turns were analyzed using PDBSum. The LOX-motif contains only helical arrangement (Figures 3b, c).
Figure 1

Ramachandran plot graphical representation with plot statistics

Figure 2

1D representation of residues found in most favoured, allowed and generous allowed region

Figure 3

(a) Modeled structure of Arachidonate 15- Lipoxygenase-B isoform d where α-helices have been represented by red color, ß-sheets by cyan, loops in green and the blue color indicates the LOX motif; (b) Figure depicting the sheets, beta hairpins, beta bulges, strands, helices, helix- helix interacs, beta turns and gamma turns present in the model; (c) 1D sequence of LOX motif where red color represents conserved histidine residues

Qualitative and quantitative study of predicted model:

VERIFY 3D details lie between 0.01 – 0.74 representing the best verified and reliable model (Figure 4). Overall quality factor was calculated with ERRAT server [26] and the modeled structure was found to have 74.738 % quality factor (Figure 5). VADAR that included accessible surface area, excluded volume, backbone and side chain dihedral angles, secondary structure, hydrogen bonding partners, hydrogen bond energies, steric quality, solvation free energy as well as local and overall fold quality yielded good results (Figure 6). Using atomic radii from Shrake method, we observed 41% residues were involved in the formation of helices, 18% in beta sheets, 40% in coils and 19% residues formed turns. Observed mean hbond distance and energy value were closely similar with expected values in hydrogen bond statistics. The obtained expected residues with hbond were 75% and we observed 74% for the predicted model. Dihedral angle statistics also represented approximately similar score with that of the expected values Tables 1a, b (see supplementary materiel). Normality test of the predicted structure checked using WHATIF was found to have fine packing quality with Z-score of 0.06. Resprox result infer that the resolution of the predicted model was 2.695 Å. Deviation of Θ angles, Bump score, χ1 score and Radius gyration Z- score indicate better quality of the model Table 2 (see supplementary materiel)). It was found that the overall quality and quantity on the basis of secondary elements of the predicted model was good and reliable. Predicted and completely analyzed model of 15-LOX-2 was successfully deposited in PMDB (Protein Model Database) [27] database with PMDBID PM0078035. The RMSD (Root Mean Square Deviation) between predicted model and template is 0.34 Å with Z-score 1.9122E+02 using AuStrAliS server [28] (Figure 7).
Figure 4

Showing VERIFY 3D interpretation

Figure 5

Quality factor obtained from ERRAT server

Figure 6

Stereo/ Packaging Quality index of predicted model

Figure 7

Superposed structure of Target (Green) and Template (Red)

Active site analysis:

Active site identification of 3D predicted model 15-LOX-2 with PMDBID PM0078035 from Homo sapiens was done using QsiteFinder. 10 possible active binding sites were localized in the predicted model (Figure 8, Figure 9). All 10 predicted site volumes with their active binding residues are reported in Table 3 (see supplementary materiel).
Figure 8

Figure showing the 10 possible active sites (in different colors) in the predicted 3D model

Figure 9

1D protein sequence representation of active sites in red color

Protein–Protein functional association network:

Protein–protein interactions occur when two or more proteins interact together to carry out their biological functions. These interactions are important for every biological process in a living cell. Protein-protein interaction helps in understanding of systems biology at structural domain and motif level and provides the basic knowledge for the application of therapeutic drug targets. In this in-silico investigation, 15-LOX-2 (NP_001132.2) protein was used to find out the association network with similar function of proteins. It was found that 15- LOX-2 has 19 major association networks with 7 types of protein families, including LOX gene family. IL (4), GPX (2 and 4), PPARG, PTGS (1 and 2), CYP (2J2, 2C8, 4A11 and 2B6), PLA (2G2A, 2G4A, 2G1B and 2G6) and A LOX (5, 15, 12 and 12B) gene families were found to have maximum STRING score 0.900 with highest confidence level (Figures 10 a, b) [29].
Figure 10

(a) Protein-Protein interaction network with highest confidence with no more than 50 interactions; (b) Tabular representation of the interacting partners of 15-LOX-2 protein.

Discussion

Protein structural modeling and simulations of 15-LOX-2 protein was successfully completed. The Ramachandran plot statistics resulted that 100% residues were found in allowed regions whereas not even a single residue was present in disallowed or in outlier regions. Qualitative and quantitative analysis of the predicted model represented the best quality model which was reliable and stable. In the predicted model, hydrogen bonds (mean hbond distance, mean hbond energy and residues with hbonds) were arranged with good confirmations. Resolution of the predicted model was 2.695 Å. After complete qualitative and quantitative analysis, predicted model has been successfully deposited in PMDB Database with PMDBID PM0078035. In LOX motif GLU369, ALA370, LEU371, THR372, HIS373, LEU374, HIS376, SER377, HIS378, THR385, LEU389, HIS394, PHE399, LYS400, LEU401, ILE403 and PRO404 residues were found to be prominent active binding sites for protein-protein, protein-drug and protein-cofactor interactions. The STRING based protein–protein interactions elucidated that 7 different protein families were associated in network with 15- LOX-2. Amongst which Interleukin 4 (IL-4) is known to participate in several B-cell activation. It is also a co-stimulator of DNA-synthesis which induces the expression of class II MHC molecules on resting B-cells. Whereas, Glutathione peroxidase (GPX) protects cells against membrane lipid peroxidation and cell death. It is required for normal sperm development, male fertility and is essential for embryonic development. Another interacting protein Peroxisome proliferator-activated receptor gamma (PPARG) is a receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids, thus controlling the peroxisomal beta-oxidation pathway of fatty acids. Prostaglandin-endoperoxide synthase 1 (PTGS) plays an important role in regulating/promoting cell proliferation in some normal and neoplastically transformed cells, whereas PTGS2 functions as a mediator of inflammation and/or plays a role in prostanoid signaling in activity-dependent plasticity. Cytochrome (CYP) P450, family2, subfamilyJ, polypeptide2 is an enzyme that metabolizes arachidonic acid, predominantly via a NADPH-dependent olefin epoxidation, to all four regioisomeric cis-epoxyeicosatrienoic acids. Phospholipase A2, group IIA (platelets, synovial fluid), belonging to PLA family of proteins, participates in the regulation of phospholipid metabolism in biomembranes including eicosanoid biosynthesis. PLA2, G-IVA (cytosolic, calcium-dependent) selectively hydrolyzes arachidonyl phospholipids in the sn-2 position releasing arachidonic acid. PLA2, G-IB (pancreas) catalyzes the calcium-dependent hydrolysis of the 2- acyl groups in 3-sn-phosphoglycerides and PLA2, G-VI (cytosolic, calcium-independent) catalyzes the release of fatty acids from phospholipids. Arachidonate 15-lipoxygenase (A LOX) converts arachidonic acid to 15S- hydroperoxy-eicosatetraenoic acid and acts on C-12 of arachidonate as well as on linoleic acid.
  14 in total

Review 1.  Mammalian 15-lipoxygenases. Enzymatic properties and biological implications.

Authors:  H Kühn; S Borngräber
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

2.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

Review 3.  Structure and mechanism of lipoxygenases.

Authors:  S T Prigge; J C Boyington; M Faig; K S Doctor; B J Gaffney; L M Amzel
Journal:  Biochimie       Date:  1997-11       Impact factor: 4.079

4.  VERIFY3D: assessment of protein models with three-dimensional profiles.

Authors:  D Eisenberg; R Lüthy; J U Bowie
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  Protein-protein docking on molecular models of Aspergillus niger RNase and human actin: novel target for anticancer therapeutics.

Authors:  Ravi Kumar Gundampati; Rajasekhar Chikati; Moni Kumari; Anurag Sharma; Daliparthy Devi Pratyush; Medicherla V Jagannadham; Chitta Suresh Kumar; Mira Debnath Das
Journal:  J Mol Model       Date:  2011-05-12       Impact factor: 1.810

6.  Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells.

Authors:  Shaohua Tang; Bobby Bhatia; Carlos J Maldonado; Peiying Yang; Robert A Newman; Junwei Liu; Dhyan Chandra; Jeanine Traag; Russell D Klein; Susan M Fischer; Dharam Chopra; Jianjun Shen; Haiyen E Zhau; Leland W K Chung; Dean G Tang
Journal:  J Biol Chem       Date:  2002-02-11       Impact factor: 5.157

Review 7.  Lipoxygenases - Structure and reaction mechanism.

Authors:  Alexandra Andreou; Ivo Feussner
Journal:  Phytochemistry       Date:  2009-09-18       Impact factor: 4.072

8.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored.

Authors:  Damian Szklarczyk; Andrea Franceschini; Michael Kuhn; Milan Simonovic; Alexander Roth; Pablo Minguez; Tobias Doerks; Manuel Stark; Jean Muller; Peer Bork; Lars J Jensen; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2010-11-02       Impact factor: 16.971

9.  The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies.

Authors:  Shin-Hua Lu; Josephine W Wu; Hsuan-Liang Liu; Jian-Hua Zhao; Kung-Tien Liu; Chih-Kuang Chuang; Hsin-Yi Lin; Wei-Bor Tsai; Yih Ho
Journal:  J Biomed Sci       Date:  2011-01-21       Impact factor: 8.410

10.  Insight to pyrazinamide resistance in Mycobacterium tuberculosis by molecular docking.

Authors:  Amirudeen Nusrath Unissa; Nagamiah Selvakumar; Sameer Hassan
Journal:  Bioinformation       Date:  2009-08-18
View more
  2 in total

1.  Functional characterization of genetic enzyme variations in human lipoxygenases.

Authors:  Thomas Horn; Kumar Reddy Kakularam; Monika Anton; Constanze Richter; Pallu Reddanna; Hartmut Kuhn
Journal:  Redox Biol       Date:  2013-11-11       Impact factor: 11.799

2.  Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach.

Authors:  Shivani Srivastava; Priya Shree; Yamini Bhusan Tripathi
Journal:  J Diabetes Metab Disord       Date:  2017-11-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.